In Re Preferential Drug Products Pricing Antitrust Litigation

OPINION AND ORDER

This litigation consists of two actions, one each pending in the Northern District of California and the Central District of California. 1 The complaints in each action are substantially similar and allege that defendants violated Section 2(f) of the Robinson-Patman Act and Sections 1 and 2 of the Sherman Act by their methods of purchasing and distributing drug products. Both actions are brought on behalf of a class of all present or former owners of retail or community pharmacies in California who are or were in competition with defendants or their affiliates from…